Sales growth coupled with clinical progress for its products helped buoy molecular imaging firm Advanced Accelerator Applications (AAA) to higher financial ground in 2014.
Total sales in 2014 increased 30% to 69.9 million euros ($92.9 million U.S.), compared with 53.8 million euros ($71.5 million) for all of 2013. The company also decreased its net loss to 10.8 million euros ($14.4 million), compared with a net loss of 12.8 million euros ($17 million) for the full year 2013.
Fourth-quarter sales increased 32% to 19.7 million euros ($24.6 million), compared with 14.9 million euros ($18.6 million) in 2013's fourth quarter.
The fourth-quarter net loss was reduced to 8.4 million euros ($10.4 million), compared with a net loss of 10.1 million euros ($12.6 million) in the same quarter a year ago.